| __timestamp | Intra-Cellular Therapies, Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 21226345 | 79838000 |
| Thursday, January 1, 2015 | 87718074 | 121816000 |
| Friday, January 1, 2016 | 93831530 | 117633000 |
| Sunday, January 1, 2017 | 79419009 | 117456000 |
| Monday, January 1, 2018 | 132166913 | 171984000 |
| Tuesday, January 1, 2019 | 89124838 | 257452000 |
| Wednesday, January 1, 2020 | 65782137 | 477643000 |
| Friday, January 1, 2021 | 88845513 | 540684000 |
| Saturday, January 1, 2022 | 134715000 | 651496000 |
| Sunday, January 1, 2023 | 180142000 | 666563000 |
Infusing magic into the data realm
In the competitive world of biotechnology, innovation is the lifeblood of success. Over the past decade, Intra-Cellular Therapies, Inc. and PTC Therapeutics, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) to bring groundbreaking therapies to market. From 2014 to 2023, PTC Therapeutics consistently outpaced Intra-Cellular Therapies in R&D spending, with an average annual investment nearly three times higher. In 2023, PTC Therapeutics allocated approximately $667 million to R&D, a 735% increase from 2014, showcasing their commitment to innovation. Meanwhile, Intra-Cellular Therapies increased their R&D spending by 748% over the same period, reaching around $180 million in 2023. This strategic focus on R&D underscores the importance of innovation in driving growth and maintaining a competitive edge in the biotech industry.
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Research and Development Investment: Zoetis Inc. vs Intra-Cellular Therapies, Inc.
Research and Development Expenses Breakdown: argenx SE vs Intra-Cellular Therapies, Inc.
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Opthea Limited
R&D Spending Showdown: Intra-Cellular Therapies, Inc. vs Apellis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Intra-Cellular Therapies, Inc. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Lantheus Holdings, Inc. and PTC Therapeutics, Inc.
R&D Spending Showdown: Amneal Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Research and Development Expenses Breakdown: PTC Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
PTC Therapeutics, Inc. vs Agios Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: PTC Therapeutics, Inc. and Iovance Biotherapeutics, Inc.
R&D Spending Showdown: PTC Therapeutics, Inc. vs Viridian Therapeutics, Inc.